No Data
(SEC Amendment) Tempus AI(TEM.US) 10% Shareholder Sells US$33.14 Million in Common Stock
$Tempus AI(TEM.US)$ 10% Shareholder KEYWELL BRADLEY A sold 946.08K shares of common stock on Jan 15, 16, 17, 2025 at an average price of $35.0251 for a total value of $33.14 million.Source:
Why Tempus AI, Inc (TEM) Soared At The Start Of The Trading Week
Moderna Spikes as Oracle's Larry Ellison Touts AI-driven MRNA Vaccines
Daily short sale tracking: Lucid Group's short volume increased by 6 million, with a short sale ratio of 15%
Lucid Group(LCID.US) ranked top of the list had the largest change in short volume (6.05 million shares), and the short volume ratio of Magnolia Oil & Gas(MGY.US) reached 50.47%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Tempus AI surged by 35% after being targeted by the "Congressional Stock God"! What other "AI + Medical" Stocks are worth paying attention to?
After CES 2025, Goldman Sachs released Research Reports highlighting several key themes and companies in the pharmaceutical and health Industry: Abbott Laboratories, Teladoc Health, and iRhythm Technologies are well positioned.
Tempus AI surged more than 16% in after-hours trading! It received a major bet from the 'Stock God of Capitol Hill'. What is the background of this company?
Since Pelosi bought Call Options, the stock price of Tempus AI has risen nearly 50%. Tempus AI focuses on applying AI technology in the field of precision medicine and launched an AI-driven personal health assistant application on Tuesday.